2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症

2017-12-19 欧洲妇科内镜学会 Gynecol Surg. 2017;14(1):27.

2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。

中文标题：

英文标题：

Recommendations for the surgicaltreatment of endometriosis—part 1:ovarian endometrioma

发布机构：

欧洲妇科内镜学会

发布日期：

2017-12-19

简要介绍：

2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。

拓展指南：与子宫内膜异位相关指南：

有关子宫内膜异位更多指南

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=23f881c001539630, title=2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症, enTitle=Recommendations for the surgicaltreatment of endometriosis—part 1:ovarian endometrioma, guiderFrom=Gynecol Surg. 2017;14(1):27., authorId=null, author=, summary=2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。 , cover=, journalId=null, articlesId=null, associationId=1022, associationName=欧洲妇科内镜学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Dec 19 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。 拓展指南：与子宫内膜异位相关指南： <ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=3221b1c00138a535" title="【精品指南】女神节来啦，健康是刚需！子宫内膜异位症诊治指南2015（附解读视频哦）" target=_blank>【精品指南】女神节来啦，健康是刚需！子宫内膜异位症诊治指南2015（附解读视频哦）</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=78b511c0013a08e2" title="2016 WES共识：子宫内膜异位症的分类" target=_blank>2016 WES共识：子宫内膜异位症的分类</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=15f8e1c0011699c1" title="子宫内膜异位症诊治指南2015" target=_blank>子宫内膜异位症诊治指南2015</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=d1ef11c0010a1230" title="2014 欧洲人类生殖及胚胎学会（ESHRE）指南：子宫内膜异位症的治疗" target=_blank>2014 欧洲人类生殖及胚胎学会（ESHRE）指南：子宫内膜异位症的治疗</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=3bfb21c000e9077a" title="2010 EMAS立场声明：既往患有子宫内膜异位症女性更年期的管理" target=_blank>2010 EMAS立场声明：既往患有子宫内膜异位症女性更年期的管理</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E5%AD%90%E5%AE%AB%E5%86%85%E8%86%9C%E5%BC%82%E4%BD%8D" target=_blank>有关子宫内膜异位更多指南</a></ul>, tagList=[TagDto(tagId=3327, tagName=手术治疗), TagDto(tagId=502, tagName=子宫内膜异位症)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5464, appHits=277, showAppHits=0, pcHits=3536, showPcHits=2371, likes=102, shares=9, comments=7, approvalStatus=1, publishedTime=Fri Jan 05 00:36:24 CST 2018, publishedTimeString=2017-12-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 05 00:36:24 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:23:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症)])

2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
2021-04-07 ms6000001015893838

已看，还可以。

106 0
[GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
2021-02-03 nina

实用的文章

104 0
[GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
2020-10-17 14686d88m59暂无昵称

实用

112 0
[GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
2018-01-05 1ddf0692m34(暂无匿称)

学习了.涨知识

105 0
[GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
2018-01-05 Y—xianghai

学习了新知识

116 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

指南&解读指南

2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症

相关指南

科室

工具

服务